Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 2:09 PM
Ignite Modification Date:
2025-12-25 @ 12:50 PM
NCT ID:
NCT04604795
Pre Assignment Details:
Total 65 participants were enrolled at one center in United Kingdom. The dose escalation committee concluded that doses higher than 160 milligram (mg) once daily (QD) (Part A Period 4 dose) should not be given. Placebo arms across similar dosing strategies in Part B were combined as pre-specified in reporting and analysis plan.
Recruitment Details:
This was a 3-part study in healthy participants. Part A was a crossover design, single-dose (SD), Part B was a parallel group, repeat oral dose and Part C was a drug:drug interaction study.
Study:
NCT04604795
Study Brief:
Results Section:
NCT04604795